Insulin-like growth factor-1 boosts the developing process of condylar hyperplasia by stimulating chondrocytes proliferation  Y. Chen, J. Ke, X. Long,

Slides:



Advertisements
Similar presentations
Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced.
Advertisements

CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation  G.-W. Kim, M.-S. Han, H.-R. Park, E.-J.
The disease modifying osteoarthritis drug diacerein is able to antagonize pro inflammatory state of chondrocytes under mild mechanical stimuli  B. Steinecker-Frohnwieser,
M. Fu, G. Huang, Z. Zhang, J. Liu, Z. Zhang, Z. Huang, B. Yu, F. Meng 
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Low-intensity pulsed ultrasound (LIPUS) treatment of cultured chondrocytes stimulates production of CCN family protein 2 (CCN2), a protein involved in.
Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads  Tatiana Gründer,
BMP-2 induces the expression of chondrocyte-specific genes in bovine synovium- derived progenitor cells cultured in three-dimensional alginate hydrogel 
Effective reduction of the interleukin-1β transcript in osteoarthritis-prone guinea pig chondrocytes via short hairpin RNA mediated RNA interference influences.
Regulation of mesenchymal stem cell chondrogenesis by glucose through protein kinase C/transforming growth factor signaling  T.-L. Tsai, P.A. Manner,
Induction of chondrogenic phenotype in synovium-derived progenitor cells by intermittent hydrostatic pressure  K. Sakao, M.D., K.A. Takahashi, M.D., Ph.D.,
IL-10 reduces apoptosis and extracellular matrix degradation after injurious compression of mature articular cartilage  P. Behrendt, A. Preusse-Prange,
Glutamate signaling in chondrocytes and the potential involvement of NMDA receptors in cell proliferation and inflammatory gene expression  T. Piepoli,
MicroRNA-92a-3p regulates the expression of cartilage-specific genes by directly targeting histone deacetylase 2 in chondrogenesis and degradation  G.
L. Pesesse, C. Sanchez, D. A. Walsh, J. -P. Delcour, C. Baudouin, P
MicroRNA-92a-3p regulates the expression of cartilage-specific genes by directly targeting histone deacetylase 2 in chondrogenesis and degradation  G.
Histone deacetylase inhibitors suppress mechanical stress-induced expression of RUNX-2 and ADAMTS-5 through the inhibition of the MAPK signaling pathway.
Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced.
M. -H. Moon, J. -K. Jeong, Y. -J. Lee, J. -W. Seol, C. J. Jackson, S
MicroRNA221-3p modulates Ets-1 expression in synovial fibroblasts from patients with osteoarthritis of temporomandibular joint  J. Xu, Y. Liu, M. Deng,
CXC chemokine ligand 12a enhances chondrocyte proliferation and maturation during endochondral bone formation  G.-W. Kim, M.-S. Han, H.-R. Park, E.-J.
Z. Zhang, Y. Kang, Z. Zhang, H. Zhang, X. Duan, J. Liu, X. Li, W. Liao 
Endoglin differentially regulates TGF-β-induced Smad2/3 and Smad1/5 signalling and its expression correlates with extracellular matrix production and.
Role of hypoxia-inducible factor-1 alpha in the regulation of plasminogen activator activity in rat knee joint chondrocytes  G. Zhu, Y. Tang, X. Liang,
Fibroblast Growth Factor 23 drives MMP13 expression in human osteoarthritic chondrocytes in a Klotho-independent manner  A. Bianchi, M. Guibert, F. Cailotto,
TGFβ inhibition during expansion phase increases the chondrogenic re-differentiation capacity of human articular chondrocytes  R. Narcisi, L. Signorile,
S. Hayashi, T. Nishiyama, Y. Miura, T. Fujishiro, N. Kanzaki, S
NF-κBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1β-induced and TNF-α-induced chondrocytes  Dr C. Lianxu, Ph.D.,
Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1β signaling in osteoarthritis fibroblast-like.
L. Raymond, S. Eck, E. Hays, I. Tomek, M. D. , S. Kantor, M. D. , M
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Histone deacetylase inhibitors suppress interleukin-1β-induced nitric oxide and prostaglandin E2 production in human chondrocytes  N. Chabane, M.Sc.,
Restriction of spontaneous and prednisolone-induced leptin production to dedifferentiated state in human hip OA chondrocytes: role of Smad1 and β-catenin.
Effect of glucosamine and its peptidyl-derivative on the production of extracellular matrix components by human primary chondrocytes  D. Stoppoloni, L.
Anti-apoptotic effect of transforming growth factor-β1 on human articular chondrocytes: role of protein phosphatase 2A  M. Lires-Deán, B.S., B. Caramés,
M.A. Greene, R.F. Loeser  Osteoarthritis and Cartilage 
Global analysis of nuclear receptor expression and dysregulation in human osteoarthritic articular cartilage  L.A. Collins-Racie, Z. Yang, M. Arai, N.
M. Akagi, M. D. , Ph. D. , A. Ueda, M. D. , T. Teramura, Ph. D. , S
Comparison of the chondrosarcoma cell line SW1353 with primary human adult articular chondrocytes with regard to their gene expression profile and reactivity.
Low-intensity pulsed ultrasound (LIPUS) treatment of cultured chondrocytes stimulates production of CCN family protein 2 (CCN2), a protein involved in.
MicroRNA-320 regulates matrix metalloproteinase-13 expression in chondrogenesis and interleukin-1β-induced chondrocyte responses  F. Meng, Z. Zhang, W.
A.J. McGregor, B.G. Amsden, S.D. Waldman  Osteoarthritis and Cartilage 
Consequences of chondrocyte hypertrophy on osteoarthritic cartilage: potential effect on angiogenesis  L. Pesesse, C. Sanchez, J.-P. Delcour, A. Bellahcène,
S. Varghese, Ph. D. , P. Theprungsirikul, B. S. , S. Sahani, B. S. , N
Comparative analysis with collagen type II distinguishes cartilage oligomeric matrix protein as a primary TGFβ-responsive gene  H. Li, D.R. Haudenschild,
N. Brandl, A. Zemann, I. Kaupe, S. Marlovits, P. Huettinger, H
Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation  A.
Cytochrome c oxidase levels in chondrocytes during monolayer expansion and after return to three dimensional culture  O.A. Boubriak, J.T.S. Brooks, J.P.G.
Expression and regulation of Toll-like receptor 2 by IL-1β and fibronectin fragments in human articular chondrocytes  S.-L. Su, M.S., C.-D. Tsai, Ph.D.,
Interleukin-1β and interleukin-6 disturb the antioxidant enzyme system in bovine chondrocytes: a possible explanation for oxidative stress generation 
M.M.-G. Sun, F. Beier  Osteoarthritis and Cartilage 
Expression of the semicarbazide-sensitive amine oxidase in articular cartilage: its role in terminal differentiation of chondrocytes in rat and human 
DIO2 modifies inflammatory responses in chondrocytes
Expression of proteinase-activated receptors (PAR)-2 in articular chondrocytes is modulated by IL-1β, TNF-α and TGF-β  Y. Xiang, M.D., K. Masuko-Hongo,
Effects of insulin-like growth factor-1 and dexamethasone on cytokine-challenged cartilage: relevance to post-traumatic osteoarthritis  Y. Li, Y. Wang,
Selenomethionine inhibits IL-1β inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes  A.W.M. Cheng,
PCB126 induces apoptosis of chondrocytes via ROS-dependent pathways
Methylation of the OP-1 promoter: potential role in the age-related decline in OP-1 expression in cartilage  R.F. Loeser, M.D., H.-J. Im, Ph.D., B. Richardson,
Glutamate signaling in chondrocytes and the potential involvement of NMDA receptors in cell proliferation and inflammatory gene expression  T. Piepoli,
Regulation of mechanical stress-induced MMP-13 and ADAMTS-5 expression by RUNX-2 transcriptional factor in SW1353 chondrocyte-like cells  T. Tetsunaga,
Matrix metalloproteinase-13 influences ERK signalling in articular rabbit chondrocytes  L.J. Raggatt, Ph.D., S.C. Jefcoat, M.S., I. Choudhury, Ph.D., S.
Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation  Y. Akasaki, M.D., S. Matsuda,
Spingosine-1-phosphate stimulates proliferation and counteracts interleukin-1 induced nitric oxide formation in articular chondrocytes  M.H. Stradner,
Comparison between chondroprotective effects of glucosamine, curcumin, and diacerein in IL-1β-stimulated C-28/I2 chondrocytes  S. Toegel, M.Pharm.S.,
Chondroitin sulfate modulation of matrix and inflammatory gene expression in IL-1β- stimulated chondrocytes – study in hypoxic alginate bead cultures 
Volume 67, Issue 6, Pages (June 2005)
Adenovirus-mediated gene transfer of glutamine: fructose-6-phosphate amidotransferase antagonizes the effects of interleukin-1β on rat chondrocytes1 1.
Chondrogenic progenitor cells promote vascular endothelial growth factor expression through stromal-derived factor-1  S. Wang, C. Zhou, H. Zheng, Z. Zhang,
Volume 70, Issue 5, Pages (September 2006)
IGF-1 regulation of type II collagen and MMP-13 expression in rat endplate chondrocytes via distinct signaling pathways  M. Zhang, Ph.D., Q. Zhou, M.D.,
Presentation transcript:

Insulin-like growth factor-1 boosts the developing process of condylar hyperplasia by stimulating chondrocytes proliferation  Y. Chen, J. Ke, X. Long, Q. Meng, M. Deng, W. Fang, J. Li, H. Cai, S. Chen  Osteoarthritis and Cartilage  Volume 20, Issue 4, Pages 279-287 (April 2012) DOI: 10.1016/j.joca.2011.12.013 Copyright © 2012 Osteoarthritis Research Society International Terms and Conditions

Fig. 1 The morphology of primary chondrocytes is shown by phase-contrast micrographs (magnification: 10×). (A) CH, day 5 (B), CH, day 12 (C) NC, day 5 (D) CH, day 12 are shown. Scale bar = 100 μm. Comparison of proliferation of chondrocytes cultured in alginate beads (E) and cultured in monolayer by MTT assay (F). Comparisons of cell amount or mean optical density (OD) value in chondrocytes of CH and NC groups were statistics analyzed by two-sample t-test. Data represent the mean ± 95% CI and the results shown represent three independent experiments. N = 3. (E) Cell amount in CH group was significantly higher than that in NC group at each time (*represents day 7, P = 0.042; day 14, P = 0.036; day 21, P = 0.002); (F) The cellular quantity in CH group chondrocytes was higher at day 5 and 7 (*represents day 5, P = 0.002; day 7, P = 0.001). Osteoarthritis and Cartilage 2012 20, 279-287DOI: (10.1016/j.joca.2011.12.013) Copyright © 2012 Osteoarthritis Research Society International Terms and Conditions

Fig. 2 The comparisons of the expression of IGF-1 protein by ELISA assay. The data are the mean ± 95% CI of the three independent experiments and normalized by cell quantity of 105 cells. With the same initial cell amount of beads per well, supernatant of culture medium from random well for 48 h was collected at day 7, 14 and 21. (A) Comparisons of levels of IGF-1 concentration between CH and NC group in alginate culture were statistics analyzed by two-sample t-test. N = 3 (*represents P < 0.0001); (B) Comparisons between CH and CH + NVP-AEW541 groups in alginate culture were statistics analyzed by two-sample t-test. N = 3 (day 7, *represents P < 0.0001; day 14, *represents P = 0.002 and day 21, *represents P = 0.01). (C) Comparisons of levels of IGF-1 concentration in CH, NC and control group in monolayer culture were statistics analyzed by ANOVA. N = 3 (*represents P < 0.0001). There was no significant difference between the two groups at 24 h and 48 h except for 72 h. At 72 h, the mean concentration of CH group and NC group was 463 pg/ml (95% CI = 281.4–644.6, N = 3) and 10 pg/ml (95% CI = 0–23.3, N = 3), respectively. The fresh culture medium was chosen as a control group and IGF-1 could be hardly detected at each time point. Osteoarthritis and Cartilage 2012 20, 279-287DOI: (10.1016/j.joca.2011.12.013) Copyright © 2012 Osteoarthritis Research Society International Terms and Conditions

Fig. 3 Real-time PCR analysis for genes of IGF-1 and IGF-1R. Total RNA obtained from chondrocytes of six beads. Each group contained 3 samples and each sample was independently performed in triplicate. 18S was chosen as the endogenous gene. Gene expression was quantified relatively using the 2−▵▵CT method. Each group is indicated at the bottom, and fold increase is indicated in the Y-axis. The bar represent mean ± 95% CI, results shown represent three independent experiments. Comparisons of IGF-1 and IGF-1R mRNA expressions alterations from between CH and NC chondrocytes were statistics analyzed by two-sample t-test. (A) The mean relative expression of IGF-1 in CH group at day 14 was 52–fold (32, 73) higher than that of NC group (*represents P = 0.007, N = 3). However, it was lower to 5.7-fold(1.5, 9.6) at day 21 (*represents P = 0.035); (B) IGF-1R gene expression in CH cells is 256-fold(11, 501)to that of NC cells at day 21 (*represents P = 0.022, N = 3). Osteoarthritis and Cartilage 2012 20, 279-287DOI: (10.1016/j.joca.2011.12.013) Copyright © 2012 Osteoarthritis Research Society International Terms and Conditions

Fig. 4 IGF-1R protein expression at CH and NC chondrocytes. GAPDH was used as a control. The bar represents mean ± 95% CI, results shown represent three independent experiments. Comparisons of IGF-1R protein expressions from between CH and NC chondrocytes were statistics analyzed by Mann–Whitney non-parametric test. The mean relative gray value of IGF-1R of CH group was 1.574-fold (1.35, 1.797) to that of NC group (*represents P = 0.037, N = 3). Osteoarthritis and Cartilage 2012 20, 279-287DOI: (10.1016/j.joca.2011.12.013) Copyright © 2012 Osteoarthritis Research Society International Terms and Conditions

Fig. 5 Effects of IGF-1 and NVP-AEW541 on CH and NC chondrocytes proliferation. Encapsulated beads were categorized and treated as described in Materials and methods. The bar represents mean ± 95% CI, results shown represent three independent experiments. Comparison of cell amount in CH and NC groups were statistics analyzed by ANOVA (N = 3). The initial cellular density was 1.66 × 105 cells/2 beads/well in each group. At day 7, visible cell amount in CH group was significantly higher than that of other three groups (*represents P = 0.024). The data showed that proliferation capacity of CH chondrocytes markedly declined with the supplement of NVP-AEW541 at day 14 (*represents P = 0.002) and day 21 (*represents P < 0.0001), while NC cells proliferated rapidly with the exposure of IGF-1 at day 14 (#represents P = 0.005) and day 21 (#represents P < 0.0001). Osteoarthritis and Cartilage 2012 20, 279-287DOI: (10.1016/j.joca.2011.12.013) Copyright © 2012 Osteoarthritis Research Society International Terms and Conditions

Fig. 6 Real-time PCR analysis of PCNA (A), G2/mitotic-specific cyclin B1 (B), M-phase inducer phosphatase expressions (C), COL2A1 and COL10A1 (D, E and F). At day 21, 100 ng/ml IGF-1 and 10 μM NVP-AEW541 was added into the fresh medium of three wells and incubated for 6 h. Thereafter, RNA was extracted from cells harvested after dissolving alginate beads and mRNA was assessed. The bar represent mean and 95% CI, results shown represent three independent experiments. Gene expression was normalized to 18S. Comparisons of PCNA, COL2A1 and COL10A1 gene expressions were statistics analyzed by ANOVA, and the data of G2/mitotic-specific cyclin B1 and M-phase inducer phosphatase genes expressions were first statistics analyzed by Kruskal–Wallis test (P = 0.041 and P = 0.024 respectively, N = 3) and the following multiple comparisons were statistics analyzed by ANOVA. (A) #represents P = 0.002, CH vs CH + NVP-AEW541, *represents P = 0.049, NC vs NC + IGF-1, N = 3; (B) #represents P = 0.046, CH vs CH + NVP-AEW541, *represents P = 0.05, NC vs NC + IGF-1, N = 3; (C) #represents P = 0.002, CH vs CH + NVP-AEW541, *represents P = 0.084, NC vs NC + IGF-1, N = 3; (D) *represents P = 0.018, CH vs NC, N = 3; (E) #represents P = 0.027, NC vs NC + IGF-1, N = 3; (F) There are no significant difference among all the groups. Osteoarthritis and Cartilage 2012 20, 279-287DOI: (10.1016/j.joca.2011.12.013) Copyright © 2012 Osteoarthritis Research Society International Terms and Conditions

Fig. 7 Effects of specific MAPK–ERK inhibitor U0126 or PI3-K inhibitor LY294002 on the CH chondrocytes proliferation. The bar represent mean and 95% CI, results shown represent three independent experiments. At each time point, mean cell viability of each sample was calculated from that of three wells, and the initial cell mount per well was 1.66 × 105 cells. Comparison of cell amount in all groups was statistics analyzed by ANOVA. Visible cell amount in CH chondrocytes treated with U0126 was significantly declined than that in untreated CH cells (#represents at day 7, P = 0.014; at day 14, P = 0.002; at day 21, P = 0.003, N = 3). On the contrary, there was no difference between CH and CH cells treated with LY294002 group (*represents at day 7, P = 0.161; at day 14, P = 0.529; at day 21, P = 0.113, N = 3). Osteoarthritis and Cartilage 2012 20, 279-287DOI: (10.1016/j.joca.2011.12.013) Copyright © 2012 Osteoarthritis Research Society International Terms and Conditions

Fig. 8 Real-time PCR analysis of cell-cycle regulator genes in CH chondrocyte. Total RNA randomly obtained from chondrocytes of six beads. Each group contained three samples. 18S was chosen as the endogenous gene. Gene expression was quantified relatively using the 2−▵▵CT method. Each group is indicated at the bottom, and fold increase is indicated in the Y-axis. The bar represents means ± SD of three independent experiments, N = 3. Comparisons of gene expressions were statistics analyzed by ANOVA. At day 21, culture medium was changed and 2 μM U0126 was added into the fresh medium and cells were incubated for 6 h. there were higher gene expression levels in CH cells than in NC cells for Cyclin D1 (P = 0.002) and CDK2 (P = 0.001), while there was a marked decline in CH cells under the incubation of U0126 for Cyclin D1 (A: *represents P = 0.03) and CDK2 (B: *represents P = 0.042). Osteoarthritis and Cartilage 2012 20, 279-287DOI: (10.1016/j.joca.2011.12.013) Copyright © 2012 Osteoarthritis Research Society International Terms and Conditions